From: Variation in plasma calcium analysis in primary care in Sweden - a multilevel analysis
Model A | Model B | Model C | Model D | |
---|---|---|---|---|
Fixed effects | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) |
Patient | ||||
Female | - | REF | REF | REF |
Male | - | 0,80 (0,77-0,83) | 0,80 (0,77-0,83) | 0,80 (0,77-0,83) |
P-Ca test 2004 | - | 1,44 (1,37-1,51) | 1,44 (1,36-1,51) | 1,44 (1,37-1,51) |
Risc score | ||||
Group 1 | - | REF | REF | REF |
Group 2 | - | 2,40 (2,15-2,70) | 2,43 (2,18-2,71) | 2,40 (2,14-2,68) |
Group 3 | - | 4,51 (4,08-5,04) | 4,56 (4,13-5,06) | 4,51 (4,08-4,97) |
Group 4 | - | 8,92 (8,11-9,87) | 9,01 (8,14-9,96) | 8,91 (8,12-9,78) |
Group 5 | - | 25,8 (23,5-28,5) | 26,1 (23,7-28,8) | 25,8 (23,5-28,4) |
Doctor | ||||
Female | - | - | REF | REF |
Male | - | - | 0,93 (0,78-1,09) | 0,95 (0,78-1,24) |
Preregistration house officer | - | - | 1,48 (1,00-2,00) | 1,51 (1,07-2,05) |
House officer | - | - | 1,69 (1,35-2,24) | 1,57 (1,26-2,09) |
GP < 46 year | - | - | 1,30 (1,02-1,76) | 1,16 (0,93-1,60) |
GP ≥ 46 year | - | - | REF | REF |
Locum < 46 year | - | - | 0,84 (0,61-1,08) | 0,78 (0,58-1,03) |
Locum ≥ 46 year | 0,73(0,57-0,94) | 0,69(0,51-0,89) | ||
HCC | ||||
Number groups include P-Ca | ||||
Group 1 | - | - | - | REF |
Group 2 | - | - | - | 2,59 (1,56-3,53) |
Group 3 | - | - | - | 2,79 (1,25-5,09) |
Random effects | Variance (95%CI) | Variance (95%CI) | Variance (95%CI) | Variance (95%CI) |
HCC (Intercept) | 0,28 (0,15-0,58) | 0,32 (0,16-0,67) | 0,32 (0,18-0,66) | 0,36 (0,16-0,80) |
MOR HCC | 1,65 (1,44-2,07) | 1,71 (1,47-2,18) | 1,72 (1,49-2,17) | 1,77 (1,48-2,34) |
Physician (Intercept) | 0,49 (0,41-0,59) | 0,59 (0,50-0,71) | 0,52 (0,43-0,62) | 0,52 (0,43-0,63) |
MOR Physician | 1,95 (1,85-2,08) | 2,09 (1,96-2,24) | 1,98 (1,87-2,12) | 1,99 (1,88-2,13) |
HCC and Physician (Intercept) | 0,77 | 0,91 | 0,84 | 0,88 |
MOR HCC+Physician | 2,31 | 2,48 | 2,4 | 2,45 |
DIC | 89 550 | 76 438 | 76 427 | 76 427 |